Menu

Study Shows ALS Patients May Benefit From More Glucose

A study co-authored by Barrow researchers Dr. Rita Sattler and Dr. Robert Bowser found that people with amyotrophic lateral sclerosis (ALS) may benefit from more glucose.

It is widely known that people with the neurodegenerative disease experience increased metabolic activity, known as hypermetabolism, but how these observations relate to metabolic changes at the cellular level has not been well understood.

The new study, led by the University of Arizona, found that increasing glucose delivery to motor neurons affected by ALS allowed those cells to live longer and function better.

Read the full story: ALS patients may benefit from more glucose

About Barrow

Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.